{
    "clinical_study": {
        "@rank": "156396", 
        "arm_group": [
            {
                "arm_group_label": "Somatostatin group", 
                "arm_group_type": "Experimental", 
                "description": "Patients with Advanced Gastric Cancer After D2 Lymph Node Dissection accept the Somatostatin medical  therapy."
            }, 
            {
                "arm_group_label": "Blank group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Use the normal saline instead of somatostatin."
            }
        ], 
        "brief_summary": {
            "textblock": "Gastric cancer radical surgery related complications are common.Somatostatin is a\n      conventional medical therapy for bleeding.This study explore the effect of Somatostatin for\n      Advanced Gastric Cancer After D2 Lymph Node dissection."
        }, 
        "brief_title": "Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Gastric Cancer After D2 Lymph Node Dissection", 
        "condition_browse": {
            "mesh_term": "Stomach Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. More than eighteen years old\n\n          2. Gastric cancer diagnosed by pathological examination\n\n          3. Be given informed consent\n\n          4. Without diabetes/hyperthyroidism/Damages of functions of heart, liver and\n             kidney/Systemic Infection/immunodeficiency\n\n        Exclusion Criteria:\n\n          1. Contraindication of vascular puncture operation\n\n          2. Patients who refused to take part in the programe\n\n          3. Poor compliance of treatment\n\n          4. Malnutrition,BMI\uff1c18\n\n          5. with pancreatectomy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914692", 
            "org_study_id": "nova-0426"
        }, 
        "intervention": {
            "arm_group_label": "Somatostatin group", 
            "description": "Somatostatin is a kind of traditional medicines ,which is for the treatment of intestinal fistula\uff0cupper gastrointestinal hemorrhage.", 
            "intervention_name": "Somatostatin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Somatostatin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 31, 2013", 
        "number_of_arms": "2", 
        "official_title": "Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection \u2014a Prospective Randomized Controlled Study", 
        "other_outcome": {
            "description": "number of patients", 
            "measure": "postoperative pancreatitis", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "overall_official": {
            "affiliation": "First Affiliated Hospital of Sun Yat-sen University", 
            "last_name": "Song Wu, Doctor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ministry of Science and Technology", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "number of patients", 
            "measure": "fistula of pancreas", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914692"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "investigator_full_name": "Wang Shaochuan", 
            "investigator_title": "Postgraduate", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "amount of bleeding after the operation", 
                "measure": "amount of bleeding", 
                "safety_issue": "Yes", 
                "time_frame": "six months"
            }, 
            {
                "description": "seroperitoneum volum of patients", 
                "measure": "seroperitoneum", 
                "safety_issue": "Yes", 
                "time_frame": "six months"
            }, 
            {
                "description": "number of patients", 
                "measure": "infection of incisional wound", 
                "safety_issue": "Yes", 
                "time_frame": "one year"
            }
        ], 
        "source": "First Affiliated Hospital, Sun Yat-Sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "First Affiliated Hospital, Sun Yat-Sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}